Rossi M, Martínez F, Kowalski A. "一种达比加群杂质129的合成方法" [P]. European Patent, EP 3475532 A1, 2019-04-10.
发明人冯建国,杨光,高志强. "Method for the Synthesis of Dabigatran Impurity 129" [P]. 中国发明专利, 专利号 CN 108767256 B, 授权公告日 2021-04-11.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 达比加群杂质129 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2010, 1350, (3), 9197-9204.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达比加群杂质129 as an Impurity". Chemosphere, 2020, 2156, (2), 6517-6544.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Dabigatran Impurity 129 Using HRMS and NMR". Anal. Chem., 2013, 466, (11), 5463-5471.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 达比加群杂质129 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2010, 1536, (3), 3422-3438.